We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Genesis Healthcare Inc | NYSE:GEN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.4204 | 0 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
ONEX CORP |
2. Issuer Name
and
Ticker or Trading Symbol
Genesis Healthcare, Inc. [ GEN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __ X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
161 BAY STREET, |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
TORONTO, A6 M5J 2S1 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Class B Common Stock | (1) | 8/24/2017 | S | 9002138 (3) | 5/18/2007 | (2) | Class A Common Stock | 9002138 | $1.00 | 0 | D | ||||
Class B Common Stock | (1) | 8/24/2017 | S | 54860 (4) | 5/18/2007 | (2) | Class A Common Stock | 54860 | $1.00 | 0 | D | ||||
Class B Common Stock | (1) | 8/24/2017 | S | 2700793 (5) | 5/18/2007 | (2) | Class A Common Stock | 2700793 | $1.00 | 0 | D | ||||
Class B Common Stock | (1) | 8/24/2017 | S | 11757791 (6) | 5/18/2007 | (2) | Class A Common Stock | 11757791 | $1.00 | 0 | I | See footnote (7) | |||
Class B Common Stock | (1) | 8/24/2017 | S | 11757791 (8) | 5/18/2007 | (2) | Class A Common Stock | 11757791 | $1.00 | 0 | I | See footnote (9) |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
ONEX CORP
161 BAY STREET TORONTO, A6 M5J 2S1 |
|
X |
|
|
|
SCHWARTZ GERALD W
161 BAY STREET 49TH FLOOR TORONTO, A6 M5J 2S1 |
|
X |
|
|
|
ONEX PARTNERS LP
C/O ONEX INVESTMENT CORPORATION 712 FIFTH AVENUE NEW YORK, NY 10019 |
|
X |
|
|
|
Onex US Principals LP
421 LEADER STREET MARION, OH 43302 |
|
X |
|
|
|
Onex Real Estate Holdings III Inc.
421 LEADER STREET MARION, OH 43302 |
|
X |
|
|
Signatures
|
||
/s/ Joshua Hausman, Managing Director of Onex Partners Manager GP ULC, the general partner of Onex Partners Manager LP, the agent of Onex Partners GP LP, the general partner of Onex Partners LP. | 8/25/2017 | |
** Signature of Reporting Person |
Date
|
|
/s/ Joshua Hausman, Director of Onex American Holdings GP LLC, the general partner of Onex US Principals LP. | 8/25/2017 | |
** Signature of Reporting Person |
Date
|
|
/s/ David Copeland, Vice President of the Onex Real Estate Holdings III Inc. | 8/25/2017 | |
** Signature of Reporting Person |
Date
|
|
s/ Andrea E. Daly, Managing Director and General Counsel of Onex Corporation | 8/25/2017 | |
** Signature of Reporting Person |
Date
|
|
s/ Andrea E. Daly, attorney-in-fact for Gerald W. Schwartz, Power of Attorney incorporation by reference to the Schedule 13G/A with respect to the Fly Leasing Limited filed by Gerald W. Schwartz (and the other signatories thereto) on April 3, 2017. | 8/25/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Genesis Healthcare Chart |
1 Month Genesis Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions